FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956331435> ?p ?o ?g. }

• W2956331435 endingPage "14" @default.
• W2956331435 startingPage "8" @default.
• W2956331435 abstract "<p>Introduction. Secondary failure to treatment with oral antidiabetic agents is defined as the absence of a favorable reaction to the oral therapy which had proved effective in the previous course of the treatment. The aim of the study is to investigate the residual effects of the short-term combination therapy with insulin on glycoregulation and insulin secretory function. Methods. The sample comprised 53 patients with type 2 diabetes mellitus (DM2) and secondary failure to treatment with oral antidiabetic agents who had been receiving combination therapy (basal insulin plus metformin) for three months. Following the evaluation of acute effects of insulin therapy, the patients had been receiving oral antihyperglycemic medications, used at the time of secondary failure, for three months, after which the residual effects of insulin therapy were estimated. Results. Three-month combination therapy significantly improved glycoregulation (fasting glycemia: 9.4 mmol/l vs. 6.1 mmol/l; postpransial glycemia: 11.5 mmol/l vs. 7.3mmol/l; daily glycemic profile: 10.0 mmol/l vs. 7.2 mmol/l) and insulin secretory parameters (insulinemia: 16.63 mU/l vs. 10.8 mU/l; C-peptid: 1.53 mg/ml vs. 1.81 mg/ml) compared with the period when secondary failure to oral therapy was observed (acute effects). Three months after the insuline therapy, glycoregulation and insulin secretory function were slightly poorerresidual effects (glycemia: 7.1mmol/l; postpransial glycemia: 8.3 mmol/l; daily glycemic profile: 8.4mmol/l; insulinemia: 13.3mU/l; C-peptid: 1.72 mg /ml). Conclusion. The reinclusion of oral antidiabetic agents after short-term insulin therapy led to mild deterioration in insulin secretory function. Nevertheless, all observed parameters of metabolic status were significantly better compared with the period prior to short-term use of insulin.</p>" @default.
• W2956331435 created "2019-07-23" @default.
• W2956331435 creator A5004391909 @default.
• W2956331435 creator A5007453259 @default.
• W2956331435 creator A5022781350 @default.
• W2956331435 creator A5053901927 @default.
• W2956331435 creator A5062748176 @default.
• W2956331435 date "2019-01-01" @default.
• W2956331435 modified "2023-10-16" @default.
• W2956331435 title "ffects of short-term combination therapy with insulin on glycoregulation and insulin secretory function in patients with type 2 diabetes mellitus and secondary failure to treatment with oral antidiabetic agents" @default.
• W2956331435 cites W2016426780 @default.
• W2956331435 cites W2025410324 @default.
• W2956331435 cites W2032967806 @default.
• W2956331435 cites W2046438754 @default.
• W2956331435 cites W2104078857 @default.
• W2956331435 cites W2159851358 @default.
• W2956331435 cites W2340898396 @default.
• W2956331435 cites W2742200852 @default.
• W2956331435 cites W2770940237 @default.
• W2956331435 cites W2804190506 @default.
• W2956331435 cites W2895533920 @default.
• W2956331435 cites W4211058450 @default.
• W2956331435 cites W4251240079 @default.
• W2956331435 cites W4256525495 @default.
• W2956331435 doi "https://doi.org/10.7251/bii1901008g" @default.
• W2956331435 hasPublicationYear "2019" @default.
• W2956331435 type Work @default.
• W2956331435 sameAs 2956331435 @default.
• W2956331435 citedByCount "0" @default.
• W2956331435 crossrefType "journal-article" @default.
• W2956331435 hasAuthorship W2956331435A5004391909 @default.
• W2956331435 hasAuthorship W2956331435A5007453259 @default.
• W2956331435 hasAuthorship W2956331435A5022781350 @default.
• W2956331435 hasAuthorship W2956331435A5053901927 @default.
• W2956331435 hasAuthorship W2956331435A5062748176 @default.
• W2956331435 hasBestOaLocation W29563314351 @default.
• W2956331435 hasConcept C126322002 @default.
• W2956331435 hasConcept C134018914 @default.
• W2956331435 hasConcept C2777180221 @default.
• W2956331435 hasConcept C2778024521 @default.
• W2956331435 hasConcept C2779306644 @default.
• W2956331435 hasConcept C2780323712 @default.
• W2956331435 hasConcept C2780473172 @default.
• W2956331435 hasConcept C2910068830 @default.
• W2956331435 hasConcept C555293320 @default.
• W2956331435 hasConcept C71924100 @default.
• W2956331435 hasConcept C90924648 @default.
• W2956331435 hasConceptScore W2956331435C126322002 @default.
• W2956331435 hasConceptScore W2956331435C134018914 @default.
• W2956331435 hasConceptScore W2956331435C2777180221 @default.
• W2956331435 hasConceptScore W2956331435C2778024521 @default.
• W2956331435 hasConceptScore W2956331435C2779306644 @default.
• W2956331435 hasConceptScore W2956331435C2780323712 @default.
• W2956331435 hasConceptScore W2956331435C2780473172 @default.
• W2956331435 hasConceptScore W2956331435C2910068830 @default.
• W2956331435 hasConceptScore W2956331435C555293320 @default.
• W2956331435 hasConceptScore W2956331435C71924100 @default.
• W2956331435 hasConceptScore W2956331435C90924648 @default.
• W2956331435 hasIssue "1" @default.
• W2956331435 hasLocation W29563314351 @default.
• W2956331435 hasLocation W29563314352 @default.
• W2956331435 hasLocation W29563314353 @default.
• W2956331435 hasOpenAccess W2956331435 @default.
• W2956331435 hasPrimaryLocation W29563314351 @default.
• W2956331435 hasRelatedWork W1966225706 @default.
• W2956331435 hasRelatedWork W1974106130 @default.
• W2956331435 hasRelatedWork W2016328345 @default.
• W2956331435 hasRelatedWork W2042819106 @default.
• W2956331435 hasRelatedWork W2048226041 @default.
• W2956331435 hasRelatedWork W2066345847 @default.
• W2956331435 hasRelatedWork W2068166803 @default.
• W2956331435 hasRelatedWork W2166209517 @default.
• W2956331435 hasRelatedWork W2171960002 @default.
• W2956331435 hasRelatedWork W2430205611 @default.
• W2956331435 hasVolume "10" @default.
• W2956331435 isParatext "false" @default.
• W2956331435 isRetracted "false" @default.
• W2956331435 magId "2956331435" @default.
• W2956331435 workType "article" @default.